Circulating exosomal microRNA profiles in migraine patients receiving acupuncture treatment: A placebo-controlled clinical trial

被引:9
|
作者
Liu, Lu [1 ]
Qi, Wenchuan [1 ,2 ]
Wang, Yanan [1 ]
Ni, Xixiu [1 ]
Gao, Shan [1 ]
Zhou, Ziyang [1 ]
Chen, Daohong [1 ]
He, Zhenxi [1 ]
Sun, Mingsheng [1 ]
Wang, Ziwen [1 ]
Cai, Dingjun [1 ,2 ]
Zhao, Ling [1 ,2 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Acupuncture & Tuina Sch, Chengdu, Sichuan, Peoples R China
[2] Acupuncture & Chronobiol Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China
来源
FRONTIERS IN MOLECULAR NEUROSCIENCE | 2023年 / 15卷
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
acupuncture; migraine; biomarker; exosome; miRNA; ONABOTULINUMTOXIN TYPE-A; PROPHYLAXIS; EFFICACY; CGRP; PAIN; PREDICTORS; EXPRESSION; HEADACHE; NETWORK; AURA;
D O I
10.3389/fnmol.2022.1098766
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BackgroundAcupuncture has a long history of being used in Chinese medicine for the treatment of migraine. However, molecular biomarkers for diagnosis and prognosis of migraine and its treatment are lacking. This study aimed to explore whether acupuncture could regulate differentially expressed exosomal miRNAs between patients with migraine without aura (MWoA) and healthy controls (HCs) and to identify diagnostic biomarkers that helped differentiate MWoA patients from HCs and identify prognostic biomarkers that helped to predict the effect of acupuncture. MethodsHere, we isolated serum exosomes from patients with MWoA and HCs before and after true and sham acupuncture treatment. Then, small RNA sequencing and bioinformatics analysis were performed to screen out key miRNAs specifically responding to acupuncture treatment. Pearson's correlation analysis was used to evaluate the correlation between miRNAs and clinical phenotypes. Finally, we applied a machine learning method to identify diagnostic biomarkers of MWoA patients and identify prognostic biomarkers that helped to predict the effect of acupuncture. ResultsSmall RNA sequencing identified 68 upregulated and 104 downregulated miRNAs in MWoA patients compared to those in HCs. Further, we identified eight upregulated and four downregulated miRNAs in migraine patients after true acupuncture treatment (trAMWoA), but not in the sham acupuncture treatment (shAMWoA) or HC group. Among them, has-miR-378a-5p was positively correlated with time unable to work, study, or do housework due to migraine (p < 0.05), whereas has-miR-605-3p was negatively correlated with the restrictive subscale of the migraine-specific quality of life questionnaire (MSQ) (p < 0.05). We then evaluated the diagnostic and prognostic potential of these 12 miRNAs in patients with MWoA. The combination of serum levels of exosomal has-miR-369-5p, has-miR-145-5p, and has-miR-5,010-3p could serve as diagnostic and prognostic biomarkers for MWoA patients following acupuncture treatment. ConclusionThis is the first study on the serum exosomal miRNA profiles of migraineurs before and after acupuncture treatment. Our results improve our understanding of the molecular functions of miRNAs in MWoA. More importantly, they expand our view of evaluating the clinical outcomes of migraine patients treated with acupuncture, using exosomal RNA markers.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Circulating exosomal microRNA profiles in migraine patients receiving acupuncture treatment: a placebo-controlled clinical trial (vol 15, 1098766, 2023)
    Liu, Lu
    Qi, Wenchuan
    Wang, Yanan
    Ni, Xixiu
    Gao, Shan
    Zhou, Ziyang
    Chen, Daohong
    He, Zhenxi
    Sun, Mingsheng
    Wang, Ziwen
    Cai, Dingjun
    Zhao, Ling
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2023, 16
  • [2] Lavender Essential Oil in the Treatment of Migraine Headache: A Placebo-Controlled Clinical Trial
    Sasannejad, Payam
    Saeedi, Morteza
    Shoeibi, Ali
    Gorji, Ali
    Abbasi, Maryam
    Foroughipour, Mohsen
    EUROPEAN NEUROLOGY, 2012, 67 (05) : 288 - 291
  • [3] A Placebo-Controlled Surgical Trial of the Treatment of Migraine Headaches DISCUSSION
    Janis, Jeffrey E.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2009, 124 (02) : 469 - 470
  • [4] Predicting Prognostic Factors in a Randomized Controlled Trial of Acupuncture Versus Topiramate Treatment in Patients With Chronic Migraine
    Yang, Chun-Pai
    Chang, Ming-Hong
    Li, Tsai-Chung
    Hsieh, Ching-Liang
    Hwang, Kai-Lin
    Chang, Hen-Hong
    CLINICAL JOURNAL OF PAIN, 2013, 29 (11) : 982 - 987
  • [5] A Randomized, Placebo-Controlled Trial of Acetaminophen for Treatment of Migraine Headache
    Prior, Mary Jane
    Codispoti, Joseph R.
    Fu, Min
    HEADACHE, 2010, 50 (05): : 819 - 833
  • [6] ACUPUNCTURE FOR THE TREATMENT OF MILD OR MODERATE ASTHMA: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL
    Bilgin, Gulden
    Arslan, Huseyin
    Balci, Nurgul
    Sunay, Didem
    NOBEL MEDICUS, 2016, 12 (02): : 31 - 37
  • [7] Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical Trial
    Lipton, Richard B.
    Munjal, Sagar
    Dodick, David W.
    Tepper, Stewart J.
    Serrano, Daniel
    Iaconangelo, Charlie
    JOURNAL OF PAIN RESEARCH, 2021, 14 : 549 - 560
  • [8] Central Mechanism of Acupuncture Treatment in Patients with Migraine: Study Protocol for Randomized Controlled Neuroimaging Trial
    Jia, Jingnan
    Yan, Chaoqun
    Zheng, Xiancheng
    Shi, Anqi
    Li, Zhijun
    Xu, Lufan
    Hui, Zhiyuan
    Chen, Yichao
    Cao, Zimin
    Wang, Jun
    JOURNAL OF PAIN RESEARCH, 2023, 16 : 129 - 140
  • [9] Tramadol/acetaminophen for the treatment of acute migraine pain: Findings of a randomized, placebo-controlled trial
    Silberstein, SD
    Freitag, FG
    Rozen, TD
    Kudrow, DB
    Hewitt, DJ
    Jordan, DM
    Fisher, AC
    Rosenthal, NR
    HEADACHE, 2005, 45 (10): : 1317 - 1327
  • [10] Acupuncture plus topiramate placebo versus topiramate plus sham acupuncture for the preventive treatment of chronic migraine: A single-blind, double-dummy, randomized controlled trial
    Liu, Lu
    Chen, Qiuyi
    Zhao, Luopeng
    Lyu, Tianli
    Nie, Limin
    Miao, Quan
    Liu, Yuhan
    Zheng, Libin
    Fu, Feiyu
    Luo, Yuxi
    Zeng, Chenxi
    Zhang, Chengcheng
    Peng, Peiyue
    Zhang, Yixin
    Li, Bin
    CEPHALALGIA, 2024, 44 (06)